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Kinetic (dynamic) vitrification is a promising trend in cryopreservation of biological materi-
als because it allows avoiding the formation of lethal intracellular ice and minimizes harmful 
effects of highly toxic penetrating cryoprotectants. A uniform cooling protocol and the same 
instruments can be used for practically all types of cells. In modern technologies, the rate 
of cooling is essentially limited by the Leidenfrost effect. We describe a novel platform for 
kinetic vitrification of biological materials KrioBlastTM that realizes hyper-fast cooling and 
allows overcoming the Leidenfrost effect. This opens prospects for creation of a novel tech-
nology of cell cryopreservation for reproductive and regenerative medicine.
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Cryopreservation of gonocytes (germplasm) and espe-
cially adult gametes and early zygotes, is the key stage 
in human reproductive technologies (fertility clinics 
and cryobanks of the sperm and oocytes), in agricul-
ture (centers of reproduction of elite animals), and in 
preservation of genetic diversity of wildlife (Frozen 
zoos) [16]. It is known that cells cannot live long in 
liquid media, while large ice crystals emerging in the 
cell during freezing can cause cell death [14]. The only 
way to store biological materials, in particular cells, 
for a long (practically infinite) time is to keep them in 
a glassy (vitreous) state. In this state, viscosity of the 
cell content and its closest microenvironment in non-
frozen channels is very high (comparable with glass 
viscosity 1013.6 Pa×sec) and the reactions of degrada-
tion are completely inhibited.
Vitrification is the key condition of long-term 
storage of biological material. At present, cell vit-
rification can be achieved by five methods [7]. The 
most common method of vitrification in cryobiology 
is slow, often programmable freezing when the bulk of 
extracellular water is transformed into ice, while intra-
cellular water escapes the cell and finally, dehydrated 
cells are vitrified in a highly concentrated solution 
(brine) in non-frozen inter-ice channels.
The second widespread method of vitrification 
implies the use of thickening agents (vitrificants) pen-
etrating into cells. These excipients in high concen-
trations (by one order of magnitude higher than the 
isotonic concentration) considerably increase viscosity 
of the intracellular and intracellular medium enabling 
vitrification even at relatively low cooling rate [5,19]. 
This type of ice-free vitrification that after a certain 
limit did not depend on cooling rate can be called 
equilibrium vitrification (E-VF), because it is free from 
both intracellular and extracellular ice. These thicken-
ing excipients in E-VF process are erroneously called 
cryoprotecting agents (CPA). However, this term is 
Cell Technologies in Biology and Medicine,  No.  4,  February,  2018
DOI 10.1007/s10517-018-4027-8
531
applicable only to slow cooling where CPA play a role 
of an osmotic buffer preventing excessive dehydration 
of cells during crystallization of the intracellular ice.
The method of kinetic vitrification (K-VF) re-
quires much less or no exogenous vitrificants, but 
manifold higher cooling rates. It also does not require 
complete vitrification of the extracellular media, be-
cause only intracellular vitrification or, at least, the 
formation of small-crystalline intracellular ice that is 
non-lethal for cells, is an obligatory condition for cell 
survival. The principal differences between E-VF and 
K-VF were previously described by us in detail [7].
These three methods of vitrification form the basis 
for modern technologies of cryogenic preservation of 
cells, components, and equipment. Vitrification at high 
(room) temperature can be realized by two methods: 
lyophilization (primary drying via ice sublimation un-
der high vacuum and secondary drying at temperatures 
above 0oC) and xeropreservation (drying at tempera-
tures above 0oC under vacuum, in air, or in an atmo-
sphere of inert gas during the whole cycle). The latter 
two methods are used for stabilization of viruses and 
prokaryotic cells, but inapplicable to eukaryotic cells; 
therefore, cryogenic methods are still the mainstream 
in germplasm biostabilization.
Slow freezing. The first attempts at sperm cryo-
preservation were in fact K-VF [7], but at the rise 
of cryobiology this method did not ensure sufficient 
stability of the biological samples. Addition of a cryo-
protectant glycerol essentially improved the results 
[2,4,18]. Glycerol and other permeable CPA allowed 
effective preservation of spermatozoa and then other 
cells, e.g. blood cells, at relatively low cooling rates. 
At the same time, long-term exposure to highly con-
centrated solutions kills the cells (the so-called “solute 
effect”). Freezing at rates surpassing the optimal rate 
of slow freezing (but insufficient for K-VF) leads to 
the formation of intracellular ice lethal for cells.
The two-factor hypothesis [15] explained the 
phenomenon of optimal rate of slow freezing, which 
promoted the development of cryopreservation tech-
niques for different cell types, including animal sperm, 
oocytes, and embryos. However, slow freezing meth-
ods have two essential drawbacks. First, the optimal 
cooling rate depends on the cell type and more so on 
their size (more precisely, on the ratio of cell volume 
to surface area); it can differ by several orders of mag-
nitude varying from several thousand degrees Celsius 
per minute for erythrocytes to fractions of degree Cel-
sius for mammalian oocytes. Moreover, the optimal 
rate depends on membrane permeability for water (Lp) 
and CPA (PCPA) and to a lesser extent on the type of the 
cryoprotectant per se. Thus, the optimal cooling rate 
for any new cell type should be determined in theoreti-
cal and experimental studies that can take a great deal 
of time. Second, specific combination of the optimal 
cooling rate and concentration of CPA is required to 
ensure maximum survival for each particular cell type. 
For instance, bone marrow stem cells demonstrate the 
best survival at cooling rate of ~2oC/min and CPA 
concentration of 1.25 M, while the maximum viability 
of bovine erythrocytes was observed at cooling rate 
of 1500oC/min and CPA concentration of 2.2 M [13]. 
Moreover, the most effective protocol of slow cryo-
preservation is an intricate multistep process [10]. It 
is specific for each particular cell type and requires 
expensive programmable freezers. The total cooling 
cycle can take long time (often more than 1 h).
Vitrification protocols: from E-VF to K-VF. 
Slow freezing showed its limitations for certain cell 
types (e.g., oocytes). Vitrification of the whole rabbit 
kidney with the use of high concentrations of vitrifi-
cants and relatively low cooling rate [5] opened a new 
chapter in cryobiology. In fact, it was E-VF that can 
be called slow in comparison with more rapid K-VF. 
However, these rates considerably surpassed the opti-
mal rates of slow cooling for the majority of cell types. 
In general, the optimal cooling rates for slow freezing 
vary from fractions of degree Celsius to hundred de-
grees Celsius per minute. For E-VF, cooling at a rate 
of several hundred and thousand degrees Celsius per 
minute is required, while K-VF totally free from ex-
ogenous vitrificants (with few exceptions, for example, 
sperm [7]) requires hyper-fast cooling (hundreds of 
thousands of degrees Celsius per minute).
Successful vitrification of mouse embryos with 
the use of the same high concentrations of vitrificants 
as for the kidney is also of paramount importance 
[19]. However, high concentrations of vitrificants (40-
60% v/v). DMSO, ethylene glycol, propylene glycol, 
or glycerol are osmotically damaging and chemically 
toxic. They cannot be used for many cells, including 
oocytes and spermatozoa; the latter can withstand 
not more than 10-15% DMSO, ethylene glycol, pro-
pylene glycol, or glycerol. Therefore, E-VF is to be 
replaced with the much more rapid K-VF, especially 
for oocytes that are intolerant to slow freezing and 
E-VF mainly because of osmotic fragility of their cy-
toskeleton. Many modern cryopreservation protocols 
and cryocontainers were designed for vitrification 
of oocytes and embryos, but they all require small 
sample volumes and precise timing, which makes 
them vulnerable to technical errors.
Leidenfrost effect — influence on the maxi-
mum cooling rate during vitrification. It is generally 
assumed that the use of small vitrification cryocon-
tainers (minicarriers) allows achieving relatively high 
(tens of thousands degrees Celsius per minute) cooling 
rates [6,9], but this assumption does not take into ac-
count the Leidenfrost effect. This effect describes the 
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Fig. 1. Carrier systems used for vitrification of oocytes and embryos. a) Surface carriers; b) closed carrier [20].
formation of a vapor film that covers “hot” sample 
(compared to liquid nitrogen temperature LN2, the 
initial difference of temperatures between the sample 
and coolant ΔTe is 120
oC and more). The formation 
of a vapor film, especially at temperatures close to 
Leidenfrost temperature, prevents heat transfer, be-
cause the heat flux from the sample surface during film 
boiling is by one to two orders of magnitude lower 
than during bubble boiling occurring at a lower ΔTe 
(<30oC). For water, the ratio of maximum heat flux qmax 
(at ΔTe=30
oC) to minimum qmin in the Leidenfrost point 
(at ΔTe=120
oC) is ~50.
For liquid nitrogen LN2, the ratio qmax/qmin (24) is 
somewhat lower, but lies in a narrower range of ΔTe 
(from 14 to 35oC for qmin and qmax, respectively) [1]. 
This corresponds to 60-fold lower heat transfer coef-
ficient (h≡q/ΔTe) in the Leidenfrost point. Taken to-
gether, these data indicate that cooling rates for small 
samples, and can be proportionally lower, cannot ex-
ceed 200,000-300,000oC/min for very small samples 
and be by one order of magnitude lower for samples 
with a volume >10 ml. At these cooling rates, rela-
tively high and potentially dangerous concentrations of 
vitrificants (DMSO and ethylene glycol in concentra-
tions ≥30%) are required.
Elimination of the Leidenfrost effect. The prob-
lem of increasing cooling rate can be radically solved 
via the development of techniques and instruments al-
lowing complete elimination of the Leidenfrost effect. 
This device should be scalable, which would easily 
increase the volume of vitrified samples. The solution 
was found in spheres that are far from biotechnol-
ogy: firefighting and rocket production, where cool-
ing liquid is supplied to the cooled object under high 
pressure that allows quick and effective cooling of hot 
(or burning) surface. This forced convection signifi-
cantly improves heat flux from the surface of the hot 
object (compared to the temperature of the coolant) 
and eliminates the Leidenfrost effect. The main differ-
ence of the proposed method of hyper-fast cooling is 
that the object is not plunged into the tank with liquid 
nitrogen, but is cooled with intense flow of cryogenic 
liquid supplied under high pressure.
KrioBlastTM-1: a pilot (first) system for hyper-
afast cooling. The system for this method of cryo-
genic cooling was developed at CELLTRONIX [8]. 
Cell Technologies in Biology and Medicine,  No.  4,  February,  2018
533
Fig. 2. KrioBlastTM-1, prototype manually operated device for hyper-fast cooling (first generation). a) 2D scheme, b) 3D configuration, c) 
photograph of the system without upper cover of the cooling chamber. 1) High-pressure vessel with liquid nitrogen (LN2); 2) cooling chamber; 
3) Dewar vessel for waste LN2; 4) adjustable heater for creation high LN2 pressure; 5) pipe with a valve for supplying LN2 at high pressure; 
6) pipe with a valve for the release of waste LN2; 7) hand plunger with a holder for a biological sample in the plate; 8) LN2; 9) nozzle gen-
erating a “cryogenic shower” with high-speed LN2 jets; 10) pipe for nitrogen vapor discharge from the cooling chamber at normal pressure 
(1 atm); 11) manual valve for nitrogen vapor discharge from high pressure LN2 tank; 12) safety valve for dumping high pressure (>2 atm) 
in LN2 vessel; 13) pressure gauge; 14) operator’s hand; 15) side view of two vacuum-tight windows: left window serves for illumination of 
the sample in LN2 with a laser beam; the right window serves for monitoring verification of the biological sample in LN2. After hyper-fast 
cooling with LN2 jets, the sample can be plunged in LN2 volume near the window. The transparency of the vitrified biological sample and 
milky color of the crystalline solution in the plate can be seen and evaluated by observing the process through the window. The vacuum 
between the two panes of windows 15 is created by means of a vacuum pump (not shown) and prevents condensation (fogging) on the 
outer (warm) pane of the window.
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The first-generation KrioBlastTM-1 was created. A 
KrioBlast-1, the prototype instrument with manual 
control of sample introduction into the cooling zone 
was constructed (Fig. 2).
In KrioBlastTM-1, the rate of cooling to cryogenic 
temperatures was determined using marker glycerol 
solutions with known cooling rate, as a function of vit-
rificant concentration. The maximum cooling rate was 
determined by the minimum glycerin concentration at 
which the sample remained vitrified (the method was 
described in detail in [21]). Indirect measurements are 
used because thermal inertia of the thermocouple at 
high cooling rates does not allow measuring cooling 
temperature, as the whole process ends in millisec-
onds, or even in microseconds.
In experiments, solutions with glycerol concen-
trations from 0 to 60% v/v with 5% intervals were 
used. During cooling, vitrification of the sample was 
observed through the right window (Fig. 2, 15). Vitrifi-
cation was monitored by sample transparency or crys-
tallization (milky color, opacity). It should be noted 
that glycerol in this case was used as a vitrificant, a 
marker of the cooling rate, but this does not mean that 
it should be used in KVF of cells.
In experiments, vitrification of 4000 µl 15% 
glycerol was achieved, which corresponded to cool-
ing rate 100,000-200,000oC/min [21]. The results of 
experiments in model solutions and on cells will be 
described in the next report.
This is the first publication on a scalable hyper-
fast cooling system to cryogenic temperatures in which 
KVF is realized. The proposed system is characterized 
by versatility and reliability, is easily operated, and 
can be automated in the future.
In preliminary experiments, high cooling rates 
were not achieved and vitrification of more diluted 
glycerol solutions was impossible for the following 
reasons:
• the sample was manually moved to the cooling 
zone (Fig. 2, 14);
• liquid nitrogen LN2 flow rate in the used cryo-
genic “Charcot’s douche” cannot be high enough 
to completely eliminate the Leidenfrost effect;
• the plate with the sample was closed with cel-
lophane plastic;
• in the future, the cell suspension should be cov-
ered and securely isolated from liquid nitrogen 
streams.
All these points are taken into account in the next 
generation of the KrioBlastTM-2 system and will be de-
scribed in the next publication, which will also include 
experimental data on KVF of pluripotent stem cells 
and spermatozoa performed with this system.
The authors are grateful to R. A. Poltavtseva (V. 
I. Kulakov National Medical Research Center of Ob-
stetrics, Gynecology, and Perinatology) for valuable 
remarks.
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